Anemia and heart failure: a cause of progression or only a consequence?

Heart Int · 2007 · PMC3184679 · PMID 21977269

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This study also showed a trend to a decrease in the risk of composite outcome (death or HF hospitalization) and mortality in the darbepoetin-α group versus placebo group (39/266, 15% vs 46/209, 22%; HR 0.67, 95% CI 0.44–1.03, p=0.06) with also a tendency to a lower mortality in the darbepoetin-α group (6% vs 9%; HR, 0.76) ( 49 , 56 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.